Patent Opposition Database

Join our community to challenge unmerited drug patents

  1. Home
  2. Drugs
  3. Dolutegravir / Lamivudine [Dovato]
  4. Abia/Gtpi Opposition, Dolutegravir/Lamivudine, (Wo2019074826 Br112020006783 0 )

Abia/Gtpi Opposition, Dolutegravir/Lamivudine, (Wo2019074826 Br112020006783 0 )

Download Pdf Subscribe to updates

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number)
WO2019074826 BR112020006783-0
Who filed
ABIA/GTPI
Country
Brazil
Opposition type
Pre-Grant
Opposition status
Under Examination
Date
23-02-2024
Patent type
Combination
No Annotations

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

Be as descriptive as necessary

Cancel

2 similar patent oppositions